TSEOQ — what changed in the latest 10-Q
A section-by-section comparison of TSEOQ's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-04-30 vs the prior 10-Q · 2025-11-07
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +55 | −83 | ~14 | 8 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | Text added/removed | +1 | 0 | ~1 | 0 |
| Risk factors | Text added/removed | 0 | 0 | ~1 | 1 |
| Other information | Text added/removed | 0 | −4 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-04-30
The Company continues to have access to capital resources through available borrowings under its debt structure. However, the Company elected not to make certain contractual interest payments during the quarter and is actively engaged in discussions with its financial stakeholders to review potentia…
The Company continues to critically review its liquidity and anticipated capital requirements, including for service of the Company's debt. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As of March 31, 2026, the Company had liqui…
The Company’s debt agreements include financial covenants, which were waived or removed through amendments obtained during the three months ended March 31, 2026. Notwithstanding the removal of these covenants as of March 31, 2026, the Company is in default on these instruments due to nonpayment of i…
As a result of these factors, the Company has concluded that substantial doubt exists about its ability to continue as a going concern within one year after the date of issuance of these consolidated financial statements.
On March 2, 2026, we received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. On March 18, 2026, the NYSE filed a Form 25 with the SEC to delist the Company’s ordinary shares fro…
Text removed vs the prior filing · source: 10-Q · 2025-11-07
Refer to the discussion below for further information and refer to “Non-GAAP Performance Measures” for discussion of our use of non-GAAP measures in evaluating our performance and a reconciliation of these measures. Other highlights for the year are described below.
On October 2, 2025, the Company, upon authorization from the Board of Directors, approved a restructuring plan to permanently close our methyl methacrylate (“MMA”) production operations in Rho, Italy and our acetone cyanohydrin (“ACH”) production operations in Porto Marghera, Italy (the “MMA Restruc…
On October 3, 2025, the Company’s Board of Directors indefinitely suspended the quarterly dividend of $0.01 per share, effective immediately, which is expected to save approximately $1.5 million annually.
On December 9, 2024, the Company executed a Transaction Support Agreement (the “TSA”) with certain supporting creditors, including holders of the Company’s 2025 Notes and 2029 Senior Notes, 2028 Refinance Credit Agreement lenders, lenders under the 2026 Revolving Facility and certain term lenders un…
On January 17, 2025, the Company completed a series of transactions contemplated by the TSA, including an offer to exchange any outstanding 5.125% senior notes due 2029 (the “2029 Senior Notes”) in exchange for new 7.625% Second Lien Senior Secured Notes due 2029 (the “2029 Refinance Senior Notes”).…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-04-30
management resources and other factors. For information regarding new matters and material developments in legal proceedings during the quarter ended March 31, 2026, see “Litigation Matters” in Note 13 to our condensed consolidated financial statements.
Other information
Text removed vs the prior filing · source: 10-Q · 2025-11-07
Angelo Chaclas, Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
(1)Unless earlier terminated pursuant to the terms of the trading arrangement.
(2)Trading arrangement entered into by the Cote 2019 Irrevocable Indenture Trust, whose shares are reported as indirectly held by Mr. Cote.
No other directors or executive officers of the Company adopted or terminated a trading arrangement intended to satisfy the affirmative defenses of Rule 10b5-1 under the Securities Exchange Act of 1934 or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K, during th…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice